Arrowhead Research | ARWR - Trade Debtors


Arrowhead Research reported $8.56M in Trade Debtors for its fiscal quarter ending in June of 2026.





Trade Debtors Change Date
Agios Pharmaceuticals USD 16.13M 5.56M Mar/2026
Alnylam Pharmaceuticals USD 912.74M 28.78M Jun/2026
Anika Therapeutics USD 29.33M 661K Dec/2025
Arrowhead Research USD 8.56M 7.13M Jun/2026
Heron Therapeutics USD 89.59M 8.54M Dec/2025
Incyte USD 1.13B 73.7M Jun/2026
Ionis Pharmaceuticals USD 58.84M 15.16M Jun/2026
Ligand Pharmaceuticals USD 54.8M 6.25M Mar/2026
Merck USD 12.21B 435M Mar/2026
Moderna USD 17M 54M Jun/2026
Nektar Therapeutics USD 3.6M 1.82M Mar/2026
Novartis USD 9.85B 252M Jun/2026
Sarepta Therapeutics USD 393.8M 154.11M Jun/2026
TG Therapeutics USD 401.56M 9.52M Jun/2026
Ultragenyx Pharmaceutical USD 60M 98M Mar/2026
Vertex Pharmaceuticals USD 2.13B 138.2M Jun/2026
Xencor USD 42.23M 30.23M Jun/2026